Latest News about NKTR
Recent news which mentions NKTR
Nektar Therapeutics (NKTR) Q4 2019 Earnings Call Transcript
February 28, 2020
Tickers
NKTR
From Motley Fool
The Daily Biotech Pulse: Gilead Kicks Off Coronavirus Drug Trials, Adcom Nod For Lily, FDA Approves Esperion's Lipid-Lowering Adjunctive Combo Therapy
February 27, 2020
From Benzinga
The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement
February 25, 2020
From Benzinga
The Week Ahead In Biotech: Biopharma Earnings Pick Up Pace
February 23, 2020
From Benzinga
85 Biggest Movers From Yesterday
February 04, 2020
From Benzinga
61 Stocks Moving In Monday's Mid-Day Session
February 03, 2020
From Benzinga
Benzinga's Top Upgrades, Downgrades For February 3, 2020
February 03, 2020
From Benzinga
26 Biotechnology Stocks Moving In Wednesday's After-Market Session
January 22, 2020
From Benzinga
36 Healthcare Stocks Moving In Wednesday's After-Market Session
January 22, 2020
From Benzinga
75 Biggest Movers From Yesterday
January 16, 2020
From Benzinga
Mid-Afternoon Market Update: OrganiGram Rises Following Q1 Results; Nektar Therapeutics Shares Plummet
January 15, 2020
From Benzinga
FDA Advisory Committee Slams Nektar's New Opioid Drug
January 15, 2020
From Motley Fool
Mid-Day Market Update: Concrete Pumping Falls On Weak Q4 Results; Fluent Shares Jump
January 15, 2020
From Benzinga
36 Stocks Moving In Wednesday's Mid-Day Session
January 15, 2020
From Benzinga
Why Nektar Therapeutics Stock Is Sinking Today
January 15, 2020
From Motley Fool
Benzinga Pro's Top 5 Stocks To Watch For Wed., Jan. 15, 2020: GS, RSX, NKTR, NVAX, ACB
January 15, 2020
From Benzinga
From Benzinga
The Daily Biotech Pulse: Nektar Withdraws Opioid Pain Drug NDA, Galapagos Takes Stake In Fibrocor, Integra Lifesciences Lowers Q4 Guidance
January 15, 2020
From Benzinga
34 Healthcare Stocks Moving In Wednesday's Pre-Market Session
January 15, 2020
From Benzinga
21 Stocks Moving in Wednesday's Pre-Market Session
January 15, 2020
From Benzinga
The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug
January 14, 2020
From Benzinga
Tickers
NKTR
From Motley Fool
55 Biggest Movers From Friday
January 13, 2020
From Benzinga
The Week Ahead In Biotech: JPMorgan Healthcare Conference, FDA Panel Reviews Opioid Pain Drugs, I-Mab's IPO
January 12, 2020
From Benzinga
Here's Why Nektar Therapeutics Shares Rose as Much as 19.7% Today
January 10, 2020
From Motley Fool
40 Stocks Moving In Friday's Mid-Day Session
January 10, 2020
From Benzinga
20 Stocks Moving in Thursday's Pre-Market Session
January 09, 2020
From Benzinga
From Benzinga
10 Stocks That Could Be Tax-Loss Buying Opportunities
December 19, 2019
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.